Detail
LncRNA Name | H19 |
Synonyms | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2 |
Region | GRCh38_11:1995176-2001470 Sequence |
Ensembl | ENSG00000130600 |
RefSeq | NR_002196 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | cervical cancer |
ICD-0-3 | C53 |
Methods | qPCR, Luciferase Reporter Assay, Western Blot. |
Sample | cervical cancer tissues |
Expression Pattern | down-regulated |
Function Description | Function assays showed that overexpression of miR-138-5p reduced cervical cancer cell proliferation, arrested cells in the G0 /G1 phase, and induced cell apoptosis in vitro. Remarkably, SIRT1 was confirmed as a direct target of miR-138-5p in cervical cancer, and miR-138-5p exerted the reduced tumor functions by suppressing SIRT1 expression. Moreover, we further identified that lncRNA H19 could act as a molecular sponge of miR-138-5p in cervical cancer progression. Taken together, these results suggested that miR-138-5p could suppress cervical cancer cell progression by targeting SIRT1.This decreased expression of miR-138-5p correlated with advanced International Federation of Gynecology and Obstetrics (FIGO) stage, poor differentiation, lymph nodes metastasis, and poor overall survival of cervical cancer patients. |
Pubmed ID | 28797320 |
Year | 2017 |
Title | Decreased Expression of MiR-138-5p by LncRNA H19 in Cervical Cancer Promotes Tumor Proliferation. |
External Links |
Links for H19 | GenBank HGNC lncrnadb Noncode |
Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.